Francesco de Rubertis
Chairman bij CENTESSA PHARMACEUTICALS PLC
Oorsprong van het eerstegraads netwerk van Francesco de Rubertis
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Medicxi Ventures (Jersey) Ltd.
 Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London.
25
| Private Company | Investment Managers | 25 |
| Public Company | Pharmaceuticals: Major | 24 | |
| Public Company | Pharmaceuticals: Major | 18 | |
Index Ventures (UK) LLP
18
| Subsidiary | Investment Managers | 18 |
BioXell SpA
 BioXell SpA BiotechnologyHealth Technology BioXell SpA provides medical services. The company researches and develops drugs to treat urological, inflammatory, and related disorders. The company was founded in 2002 and is headquartered in Segrate, Italy.
17
| Extinct | Biotechnology | 17 |
University of Geneva
16
| College/University | Other Consumer Services | 16 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA.
9
| Extinct | Pharmaceuticals: Major | 9 |
Synox Therapeutics Ltd.
 Synox Therapeutics Ltd. BiotechnologyHealth Technology Synox Therapeutics Ltd. a clinical stage biopharmaceutical company. The company is headquartered in Dublin, Ireland.
7
| Holding Company | Biotechnology | 7 |
Levicept Ltd.
 Levicept Ltd. Pharmaceuticals: GenericHealth Technology Levicept Ltd. develops a biological therapy for the treatment of osteoarthritis and chronic pain. Its treatments include p75NTR-Fc and LEVI-04. The company was founded by Simon Lempriere Westbrook on August 23, 2012 and is headquartered in Sandwich, the United Kingdom.
7
| Holding Company | Pharmaceuticals: Generic | 7 |
Xenikos BV
 Xenikos BV Medical SpecialtiesHealth Technology Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands.
5
| Holding Company | Medical Specialties | 5 |
Hamilton Pharmaceuticals, Inc.
 Hamilton Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Hamilton Pharmaceuticals, Inc. develops and supplies pharmaceuticals. It also develops and commercializes novel medical treatments for central nervous system disease. The company was founded in April 2004 and is headquartered in Washington, DC.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
SDS Therapeutics Ltd.
 SDS Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services SDS Therapeutics Ltd. is a British biotechnology company founded in 2020 that provides research and development services. The company is based in Cambridge, UK.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Inexia Ltd.
 Inexia Ltd. Medical SpecialtiesHealth Technology Inexia Ltd. develops intranasal orexin positive modulators for the treatment of narcolepsy. The company is headquartered in London, the United Kingdom.
3
| Holding Company | Medical Specialties | 3 |
Critical Pressure Ltd.
 Critical Pressure Ltd. Pharmaceuticals: MajorHealth Technology Critical Pressure Ltd. engages in research and experimental development on biotechnology. The firm develops products to treat vascular dysfunction and shock. The company is headquartered in Babraham, the United Kingdom.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Rivus Pharmaceuticals, Inc.
 Rivus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rivus Pharmaceuticals, Inc. is a company dedicated to improving metabolic health by advancing a new class of medicines called controlled metabolic accelerators (CMAs). The company is based in Charlottesville, VA. Jayson Donald Alexander Dallas has been the CEO of the company since 2021. The company is a leader in mitochondrial biology and is developing a new class of medicines to address a primary driver of cardio-metabolic disease: obesity. Rivus' lead CMA is the investigational small molecule HU6 in development to treat obesity and associated metabolic diseases, including heart failure with preserved ejection fraction (HFpEF), metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic dysfunction-associated steatohepatitis (MASH), and type 2 diabetes.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Egalet A/S
 Egalet A/S Pharmaceuticals: MajorHealth Technology Egalet A/S operates as a specialty pharmaceuticals company. It develops opioid formulations for pain management based on abuse deterrent prolonged release erosion matrix technology in Denmark. The company develops prolonged and delayed release therapeutics for chronic pain management, including Parvulet, a delivery platform for facilitating dispensing of oral doses to pediatric and geriatric patient segments; and Egalet morphine. The company was founded by Jan Quistgaard in 1995 and is headquartered in Vaerloese, Denmark.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Orexia Therapeutics Ltd.
 Orexia Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Orexia Ltd. develop orally administered orexin positive modulators for the treatment of neurological diseases. The company was founded on October 5, 2018 and is headquartered in London, the United Kingdom.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
UltraHuman Ltd.
 UltraHuman Ltd. Miscellaneous Commercial ServicesCommercial Services UltraHuman Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Sandwich, the United Kingdom.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Francesco de Rubertis via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer Director of Finance/CFO | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor Director/Board Member | |
| COMPUGEN LTD. | Biotechnology | Chairman Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| NEUREN PHARMACEUTICALS LIMITED | Pharmaceuticals: Generic | Chairman Chief Tech/Sci/R&D Officer | |
| IPSEN | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
 F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Medical Specialties | Director/Board Member Chief Executive Officer | |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
OANDA Corp.
 OANDA Corp. Packaged SoftwareTechnology Services OANDA Corp. provides currency data, foreign exchange and contract for difference trading, payment, and data services for businesses and investors. The firm operates an online foreign exchange trading platform, FXTrade, which provides real-time access to the foreign exchange market. The company was founded by Richard Olsen and Michael Stumm in 1996 and is headquartered in San Francisco, CA. | Packaged Software | Director/Board Member Director/Board Member | |
| VEEVA SYSTEMS INC. | Packaged Software | Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Oxford | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
| Imperial College London | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Index Ventures SA
 Index Ventures SA Investment ManagersFinance Index Ventures SA (Index Ventures) is a venture capital firm founded in 1996 by Neil Alexander Rimer, Gluseppe Zocco and Gerald Rimer. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Founder Private Equity Investor Private Equity Analyst Private Equity Investor Private Equity Investor Private Equity Analyst Private Equity Investor Private Equity Analyst | |
Niederer Kraft Frey AG
 Niederer Kraft Frey AG Miscellaneous Commercial ServicesCommercial Services Niederer Kraft Frey AG operates as a full-service Swiss law firm. The company provides legal services. It specializes in strategic goals implementation and strengthening of business. The company was founded in 1936 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Graduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| INSEAD | College/University | Masters Business Admin Corporate Officer/Principal | |
| University of Fribourg | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Lausanne | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Private Equity Investor Corporate Officer/Principal Private Equity Investor | |
The Swiss Institute of Bioinformatics
 The Swiss Institute of Bioinformatics Miscellaneous Commercial ServicesCommercial Services The Swiss Institute of Bioinformatics is an academic not-for-profit organization based in Basel, Switzerland. The institute provides over 160 high-quality databases and software tools to the life science community. Its mission is to lead and coordinate the field of bioinformatics. SIB experts and resources are involved in developing dedicated data services, analysis tools, and improving knowledge sharing to fight the COVID-19 pandemic. The institute has established close partnerships and collaborations with leading institutions at national and international levels. SIB values equality, diversity, and inclusion and trains the next generation of bioinformaticians to ensure that life scientists make the best use of bioinformatics and SIB's resources. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| SAGENT PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chairman | |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
SIX Swiss Exchange AG
 SIX Swiss Exchange AG Investment Banks/BrokersFinance SIX Swiss Exchange AG operates as a stock exchange. It distributes a range of indices; and offers market data for shares, bonds, ETFs and funds, ETPs, indices, statistics, and data services. The firm enables to list and trade in segments, including equities, bonds, exchange traded funds (ETFs), exchange traded products (ETPs), derivatives, sponsored funds, sponsored foreign shares, warrants, and structured products. The company was founded in 1850 and is headquartered in Zurich, Switzerland. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
Mind-NRG SARL
 Mind-NRG SARL Medical/Nursing ServicesHealth Services Mind-NRG SARL specializes in research and development programs with focus on the treatment psychiatric and neurologic diseases. The company was founded in 2010 and is headquartered in Geneva, Switzerland. | Medical/Nursing Services | President Chairman Director/Board Member Director/Board Member | |
Azek AG
 Azek AG Miscellaneous Commercial ServicesCommercial Services Azek AG offers various training programs for Swiss financial professionals, including courses such as CIIA, CIWM, ESG, CESGA, ESG-CA, FINSA, FMO, and FMT. The private company is based in Bulach, Switzerland. Upon completion, successful participants are awarded the Federal Diploma of Technician in Financial Market Operations (FMT). Additionally, the ESG-CA course qualifies advisors to competently inform their clients about ESG and suggest sustainable investment solutions. The CEO of the Swiss company is Andreas Jacobs. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Index Venture Management (US), Inc.
 Index Venture Management (US), Inc. Investment ManagersFinance Founded in 2011, Index Venture Management (US), Inc. is a venture capital firm located in San Francisco. The firm is a subsidiary of Index Venture Management SA | Investment Managers | Founder Chief Tech/Sci/R&D Officer | |
| Perseis Therapeutics Ltd. | Director/Board Member Director/Board Member | ||
Ashworth & Parker Ltd.
 Ashworth & Parker Ltd. Apparel/Footwear RetailRetail Trade Ashworth & Parker Ltd. provides online shopping services. It offers cloths, footwear, bags, belts, hats, scarves, gloves, socks, sunglasses, jewelry, watches, and wallets & key chains. The company was founded in 2005 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Apparel/Footwear Retail | Director/Board Member Director/Board Member | |
Capella Bioscience Ltd.
 Capella Bioscience Ltd. Pharmaceuticals: MajorHealth Technology Capella Bioscience Ltd. develops medicines based on monoclonal antibodies to the next generation therapeutic targets in oncology and autoimmune disease. The company was founded by Steve Holmes in 2014 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Inhibitaxin Ltd.
 Inhibitaxin Ltd. BiotechnologyHealth Technology Inhibitaxin Ltd. engages in research and development on biotechnology. The company was founded by Simon Lempriere Westbrook and Kevin S. Johnson in 2013 and is headquartered in Kent, the United Kingodm. | Biotechnology | Founder Director/Board Member Founder | |
Z Factor Ltd.
 Z Factor Ltd. BiotechnologyHealth Technology Z Factor Ltd. operates as a drug discovery company. It identifies and develops therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was founded by James Huntington in 2015 and is headquartered in Babraham, the united Kingdom. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Founder | |
ApcinteX Ltd.
 ApcinteX Ltd. BiotechnologyHealth Technology ApcinteX Ltd. develops and markets anticoagulant APC pathway to treat haemophilia. The company is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member Founder | |
| ARAVIVE, INC. | Biotechnology | Chairman Chief Executive Officer Chief Administrative Officer Director of Finance/CFO | |
| DYNE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| KINNATE BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
F-star Therapeutics Ltd.
 F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology F-Star Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of immune-oncology drugs for antibody therapies. The company was founded in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| F-STAR THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
F-star Biotechnology Ltd.
 F-star Biotechnology Ltd. BiotechnologyHealth Technology F-Star Biotechnology Ltd. is a biopharmaceutical company. It discovers, develops, and manufactures bispecific antibody products. The company is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 19 |
| Verenigd Koninkrijk | 15 |
| Zwitserland | 10 |
| Frankrijk | 3 |
| Nederland | 3 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Finance | 6 |
| Technology Services | 4 |
Operationeel
| Director/Board Member | 646 |
| Corporate Officer/Principal | 209 |
| Independent Dir/Board Member | 107 |
| Founder | 83 |
| Chief Executive Officer | 78 |
Sterkste connecties
| Insiders | |
|---|---|
| Paul Sekhri | 61 |
| Daniel H. Rimer | 55 |
| Srini Akkaraju Akkaraju | 54 |
| Raj Bhikhu Parekh | 50 |
| Eliot Forster | 35 |
| Michèle Ollier | 33 |
| Jay Shepard | 30 |
| Bob Flanagan Flanagan | 30 |
| David Grainger | 29 |
| Jean-Pierre Danthine | 27 |
| Giuseppe Zocco | 26 |
| Douglas Williams | 25 |
| Mary Lynne Hedley | 24 |
| Brett Zbar | 23 |
| Frank Kung | 22 |
- Beurs
- Insiders
- Francesco de Rubertis
- Bedrijfsconnecties
